Characterization of anti-CD19 chimeric antigen receptor (CAR) T cell-mediated tumor microenvironment immune gene profile in a multicenter trial (ZUMA-1) with axicabtagene ciloleucel (axi-cel, KTE-C19).

被引：46

作者：

Galon, Jerome

Rossi, John

Turcan, Sarah

Danan, Corinne

Locke, Frederick Lundry

Neelapu, Sattva Swarup

Miklos, David Bernard

Bartlett, Nancy L.

Jacobson, Caron Alyce

Braunschweig, Ira

Oluwole, Olalekan O.

Siddiqi, Tanya

Lin, Yi

Timmerman, John

Reagan, Patrick Michael

Lekakis, Lazaros J.

机构：

[1] Lab Integrat Canc Immunol, INSERM, Paris, France

[2] Kite Pharma Inc, Santa Monica, CA USA

[3] HalioDx, Marseille, France

[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

[7] Washington Univ, Sch Med, St Louis, MO USA

[8] Siteman Canc Ctr, St Louis, MO USA

[9] Dana Farber Canc Inst, Boston, MA 02115 USA

[10] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA

[11] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[12] City Hope Comprehens Canc Ctr, Duarte, CA USA

[13] Mayo Clin, Rochester, MN USA

[14] Univ Calif Los Angeles, Los Angeles, CA USA

[15] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA

[16] Univ Miami, Miami, FL USA

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.3025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3025

引用

页数：5